Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry was added: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the document or system rather than changes visible to users.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe site’s revision/version indicator changed from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details content.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter revision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page update only shows a new revision number, changing from v3.4.1 to v3.4.2, with no observable changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.